283 related articles for article (PubMed ID: 31790121)
1. Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion.
Kotecha R; Sahgal A; Rubens M; De Salles A; Fariselli L; Pollock BE; Levivier M; Ma L; Paddick I; Regis J; Sheehan J; Yomo S; Suh JH
Neuro Oncol; 2020 Mar; 22(3):318-332. PubMed ID: 31790121
[TBL] [Abstract][Full Text] [Related]
2. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
Pomeraniec IJ; Xu Z; Lee CC; Yang HC; Chytka T; Liscak R; Martinez-Alvarez R; Martinez-Moreno N; Attuati L; Picozzi P; Kondziolka D; Mureb M; Bernstein K; Mathieu D; Maillet M; Ogino A; Long H; Kano H; Lunsford LD; Zacharia BE; Mau C; Tuanquin LC; Cifarelli C; Arsanious D; Hack J; Warnick RE; Strickland BA; Zada G; Chang EL; Speckter H; Patel S; Ding D; Sheehan D; Sheehan K; Kvint S; Buch LY; Haber AR; Shteinhart J; Vance ML; Sheehan JP
J Neurosurg; 2022 Mar; 136(3):813-821. PubMed ID: 34560630
[TBL] [Abstract][Full Text] [Related]
3. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
Milano MT; Grimm J; Soltys SG; Yorke E; Moiseenko V; Tomé WA; Sahgal A; Xue J; Ma L; Solberg TD; Kirkpatrick JP; Constine LS; Flickinger JC; Marks LB; El Naqa I
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):87-99. PubMed ID: 29534899
[TBL] [Abstract][Full Text] [Related]
4. The Role of Stereotactic Radiosurgery for Functioning and Nonfunctioning Pituitary Adenomas.
Lehrer EJ; Kowalchuk RO; Trifiletti DM; Sheehan JP
Neurol India; 2023; 71(Supplement):S133-S139. PubMed ID: 37026344
[TBL] [Abstract][Full Text] [Related]
5. Biological Effective Dose as a Predictor of Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis and Cohort Study of Patients Treated Using Contemporary Techniques.
Graffeo CS; Perry A; Link MJ; Brown PD; Young WF; Pollock BE
Neurosurgery; 2021 Mar; 88(4):E330-E335. PubMed ID: 33469668
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
Redmond KJ; De Salles AAF; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan J; Suh J; Yomo S; Sahgal A
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):68-80. PubMed ID: 33891979
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.
Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Sitathanee C; Ruangkanchanasetr R; Yongvithisatid P
J Neurooncol; 2018 Sep; 139(3):679-688. PubMed ID: 29846895
[TBL] [Abstract][Full Text] [Related]
8. Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35Gy in 5 fractions.
Sumodhee S; Atallah V; Kinj R; Doyen J; L'Homel B; Gillon P; Paquis P; Almairac F; Hieronimus S; Schiappa R; Sadoul JL; Sumodhee D; Pontikos N; Richier Q; Hannoun-Levi JM; Scouarnec C; Chevalier N; Bondiau PY
Cancer Radiother; 2022 Jun; 26(4):557-562. PubMed ID: 34711487
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations.
Mathieu D; Kotecha R; Sahgal A; De Salles A; Fariselli L; Pollock BE; Levivier M; Ma L; Paddick I; Regis J; Yomo S; Suh JH; Rubens M; Sheehan JP
J Neurosurg; 2022 Mar; 136(3):801-812. PubMed ID: 34479203
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
[TBL] [Abstract][Full Text] [Related]
11. Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.
Graffeo CS; Link MJ; Brown PD; Young WF; Pollock BE
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):618-623. PubMed ID: 29678524
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Nonfunctioning Pituitary Adenoma.
Khattab MH; Sherry AD; Xu MC; Kelly P; Anderson JL; Luo G; Chambless LB; Cmelak AJ; Attia A
J Neurol Surg B Skull Base; 2021 Jul; 82(Suppl 3):e51-e58. PubMed ID: 34306917
[No Abstract] [Full Text] [Related]
13. Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Ironside N; Snyder H; Xu Z; Schlesinger D; Chen CJ; Vance ML; Hong GK; Jane JA; Sheehan JP
J Neurooncol; 2022 May; 158(1):41-50. PubMed ID: 35461378
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis.
Li X; Li Y; Cao Y; Li P; Liang B; Sun J; Feng E
J Neurol Sci; 2017 Jan; 372():110-116. PubMed ID: 28017195
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife
Puataweepong P; Dhanachai M; Swangsilpa T; Sitathanee C; Ruangkanchanasetr R; Hansasuta A; Pairat K
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e247-e254. PubMed ID: 34310064
[TBL] [Abstract][Full Text] [Related]
17. Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis.
Palmisciano P; Ogasawara C; Ogasawara M; Ferini G; Scalia G; Haider AS; Bin Alamer O; Salvati M; Umana GE
Pituitary; 2022 Jun; 25(3):404-419. PubMed ID: 35349010
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
Graffeo CS; Donegan D; Erickson D; Brown PD; Perry A; Link MJ; Young WF; Pollock BE
Neurosurgery; 2020 Sep; 87(3):538-546. PubMed ID: 32267504
[TBL] [Abstract][Full Text] [Related]
19. Repeat stereotactic radiosurgery for Cushing's disease: outcomes of an international, multicenter study.
Mehta GU; Ding D; Gupta A; Kano H; Sisterson ND; Martinez-Moreno N; Kršek M; Yang HC; Lee CC; Liščák R; Martinez-Alvarez R; Lunsford LD; Vance ML; Sheehan JP
J Neurooncol; 2018 Jul; 138(3):519-525. PubMed ID: 29500664
[TBL] [Abstract][Full Text] [Related]
20. Target delineation and optimal radiosurgical dose for pituitary tumors.
Minniti G; Osti MF; Niyazi M
Radiat Oncol; 2016 Oct; 11(1):135. PubMed ID: 27729088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
